Argenx
ARGX
#550
Rank
S$50.96 B
Marketcap
$852.36
Share price
-0.48%
Change (1 day)
68.89%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.63

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.66. In 2022 the company made an earnings per share (EPS) of -$17.84.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.63-68.44%
2022-$17.84